Literature DB >> 16149051

The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis.

Peter V N Bodine1, Julia Billiard, Robert A Moran, Helga Ponce-de-Leon, Sean McLarney, Annamarie Mangine, Melissa J Scrimo, Ramesh A Bhat, Barbara Stauffer, Jack Green, Gary S Stein, Jane B Lian, Barry S Komm.   

Abstract

Mechanisms controlling human bone formation remain to be fully elucidated. We have used differential display-polymerase chain reaction analysis to characterize osteogenic pathways in conditionally immortalized human osteoblasts (HOBs) representing distinct stages of differentiation. We identified 82 differentially expressed messages and found that the Wnt antagonist secreted frizzled-related protein (sFRP)-1 was the most highly regulated of these. Transient transfection of HOBs with sFRP-1 suppressed canonical Wnt signaling by 70% confirming its antagonistic function in these cells. Basal sFRP-1 mRNA levels increased 24-fold during HOB differentiation from pre-osteoblasts to pre-osteocytes, and then declined in mature osteocytes. This expression pattern correlated with levels of cellular viability such that the pre-osteocytes, which had the highest levels of sFRP-1 mRNA, also had the highest rate of cell death. Basal sFRP-1 mRNA levels also increased 29-fold when primary human mesenchymal stem cells were differentiated to osteoblasts supporting the developmental regulation of the gene. Expression of sFRP-1 mRNA was induced 38-fold following prostaglandin E2 (PGE2) treatment of pre-osteoblasts and mature osteoblasts that had low basal message levels. In contrast, sFRP-1 expression was down-regulated by as much as 80% following transforming growth factor (TGF)-beta1 treatment of pre-osteocytes that had high basal mRNA levels. Consistent with this, treatment of pre-osteoblasts and mature osteoblasts with PGE(2) increased apoptosis threefold, while treatment of pre-osteocytes with TGF-beta1 decreased cell death by 50%. Likewise, over-expression of sFRP-1 in HOBs accelerated the rate of cell death threefold. These results establish sFRP-1 as an important negative regulator of human osteoblast and osteocyte survival. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16149051     DOI: 10.1002/jcb.20599

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  68 in total

Review 1.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

2.  Regulation of SFRP-1 expression in the rat dental follicle.

Authors:  Dawen Liu; Shaomian Yao; Gary E Wise
Journal:  Connect Tissue Res       Date:  2012-03-14       Impact factor: 3.417

Review 3.  Pathogenesis of osteoporosis: concepts, conflicts, and prospects.

Authors:  Lawrence G Raisz
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 4.  Wnt signaling and skeletal development.

Authors:  Fei Liu; Sean Kohlmeier; Cun-Yu Wang
Journal:  Cell Signal       Date:  2007-11-28       Impact factor: 4.315

5.  Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.

Authors:  Lilian I Plotkin; Virginia Lezcano; Jeff Thostenson; Robert S Weinstein; Stavros C Manolagas; Teresita Bellido
Journal:  J Bone Miner Res       Date:  2008-11       Impact factor: 6.741

6.  Brachy-syndactyly caused by loss of Sfrp2 function.

Authors:  Roy Morello; Terry K Bertin; Silke Schlaubitz; Chad A Shaw; Sujatha Kakuru; Elda Munivez; Pia Hermanns; Yuqing Chen; Bernhard Zabel; Brendan Lee
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

Review 7.  Nitric oxide signaling in mechanical adaptation of bone.

Authors:  J Klein-Nulend; R F M van Oers; A D Bakker; R G Bacabac
Journal:  Osteoporos Int       Date:  2013-12-10       Impact factor: 4.507

Review 8.  WNT Signaling in osteoarthritis and osteoporosis: what is the biological significance for the clinician?

Authors:  Liesbet Lodewyckx; Rik J U Lories
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

9.  Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.

Authors:  Larry Pederson; Ming Ruan; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

10.  Hydrogen Sulfide Is a Novel Regulator of Bone Formation Implicated in the Bone Loss Induced by Estrogen Deficiency.

Authors:  Francesco Grassi; Abdul Malik Tyagi; John W Calvert; Laura Gambari; Lindsey D Walker; Mingcan Yu; Jerid Robinson; Jau-Yi Li; Gina Lisignoli; Chiara Vaccaro; Jonathan Adams; Roberto Pacifici
Journal:  J Bone Miner Res       Date:  2015-12-23       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.